Amyloid Beta (Abgr;) Peptide and Factors that Play Important Roles in Alzheimerrsquo;s Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|23|9|884-892

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.23, Iss.9, 2016-03, pp. : 884-892

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

&bgr;-Amyloid therapies in Alzheimer’s disease

By Jhee S.   Shiovitz T.   Crawford A.W.   Cutler N.R.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 4, 2001-04 ,pp. : 593-605

Informa Healthcare

Access to resources Recommend Favorite

Emerging amyloid beta (Ab) peptide modulators for the treatment of Alzheimer's disease (AD)

By Lukiw Walter J  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 2, 2008-06 ,pp. : 255-271

Informa Healthcare

Access to resources Recommend Favorite

Peptide Inhibitors of Beta Amyloid Aggregation

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 4, 2002-04 ,pp. : 417-423

Bentham Science Publishers

Access to resources Recommend Favorite

Physiological Roles of Amyloid- and Implications for its Removal in Alzheimer’s Disease

By Glenda M. Bishop   Stephen R. Robinson  

Drugs & Aging, Vol. 21, Iss. 10, 2004-01 ,pp. : 621-630

Adis International

Access to resources Recommend Favorite

β-Amyloid peptide as a target for treatment of Alzheimer’s disease

By Conde Santiago  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 4, 2002-04 ,pp. : 503-512

Informa Healthcare

Access to resources Recommend Favorite